← Eichor
Condition: Lipoprotein A Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Lipoprotein A

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio
Phase 3 · 249 location(s) · Amgen · NCT07136012A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)
Phase 1 · 1 location(s) · CSL Behring · NCT07619820Heart CT Imaging to Detect Early Coronary Artery Disease in First-Degree Relatives With High or Low Lipoprotein(a) Ident
Phase N/A · 1 location(s) · E.S.stroes · NCT06995183An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · 635 location(s) · Novartis Pharmaceuticals · NCT07517263AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION)
Phase N/A · 1 location(s) · University of Galway · NCT07577609Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Establish
Phase 3 · 95 location(s) · Novartis Pharmaceuticals · NCT06813911A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Particip
Phase 1 · 6 location(s) · AstraZeneca · NCT06980428Impact of the Corrie Lipids Digital Health Program on Lipid Optimization
NA · 1 location(s) · Johns Hopkins University · NCT07478887Low-carbohydrate Diet and Low-Density Lipoprotein - Cholesterol (LDL-c) Interindividual Variability
NA · 1 location(s) · University of Bath · NCT07675603Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
Phase 3 · 40 location(s) · Amgen · NCT07293260Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Phase 3 · 772 location(s) · Eli Lilly and Company · NCT07157774Familial Hypercholesterolemia Interpretive Comment - Nudging to Detection.
NA · 2 location(s) · Odense University Hospital · NCT05614219Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a
NA · 1 location(s) · Duke University · NCT06471036A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Phase 1 · 2 location(s) · Monash University · NCT07428473Human Milk Oligosaccharide-Based Synbiotic Supplement for Intestinal Microbiota Dysbiosis
EARLY_Phase 1 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT06615986Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-El
NA · 2 location(s) · Sin Gon Kim · NCT07359105Pelacarsen Roll-over Extension Program
Phase 3 · 97 location(s) · Novartis Pharmaceuticals · NCT06875973Testing for Increased Lipoproteins (a) [LP(a)] in Lymphedema Patients: Li-LY
NA · 2 location(s) · Centre Hospitalier Universitaire de Nice · NCT05962827Lipid Screening Study
Phase N/A · 1 location(s) · University of Central Florida · NCT07579325The Effect of Improved Glycemic Control on the Composition and Function of High-Density Lipoproteins (HDL) in Patients W
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire Dijon · NCT07564752Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterole
Phase 3 · 19 location(s) · Novartis Pharmaceuticals · NCT06597006Atlantic Lipid Lowering Treatment Optimization Program
NA · 2 location(s) · Atlantic Health System · NCT06439654The Effect of Lipoprotein (a) on Arterial Stiffness, Endothelial Function and Myocardial Deformation
Phase N/A · 2 location(s) · University of Athens · NCT07324902Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Phase 3 · 84 location(s) · Immunovant Sciences GmbH · NCT07039916The Prevalence of Hyper-Lp(a)-Emia in the PMMHRI-Lp(a) Registry
Phase N/A · 1 location(s) · Polish Mother Memorial Hospital Research Institute · NCT06610669Cardiovascular Risk in Children With Chronic Conditions Study
Phase N/A · 3 location(s) · Semmelweis University · NCT07086989A Study of SRSD216 in Patients With Elevated Lipoprotein (a)
Phase 1/Phase 2 · 1 location(s) · Sirius Therapeutics Co., Ltd. · NCT07172646NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia
EARLY_Phase 1 · 1 location(s) · First Affiliated Hospital Xi'an Jiaotong University · NCT06125847A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calci
Phase 2 · 140 location(s) · Novartis Pharmaceuticals · NCT05646381Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Phase 3 · 66 location(s) · Novartis Pharmaceuticals · NCT06597019
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.